Current status of the molecular mechanisms of anticancer drug-induced apoptosisRyungsa Kim, Tetsuya Toge, Kazuaki Tanabe et al.|Cancer Chemotherapy and Pharmacology|2002Cited by 255
The role of Fas ligand and transforming growth factor β in tumor progressionRyungsa Kim, Tetsuya Toge, Manabu Emi et al.|Cancer|2004Cited by 135
Targeted therapy against Bcl-2-related proteins in breast cancer cellsManabu Emi, Tetsuya Toge, Ryungsa Kim et al.|Breast Cancer Research|2005Cited by 114
Therapeutic potential of antisense Bcl‐2 as a chemosensitizer for cancer therapyRyungsa Kim, Tetsuya Toge, Manabu Emi et al.|Cancer|2004Cited by 110
Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugsKazuaki Tanabe, Tetsuya Toge, Ryungsa Kim et al.|International Journal of Oncology|2003Cited by 37